Soleno Therapeutics (SLNO) Cost of Revenue: 2014-2017
Historic Cost of Revenue for Soleno Therapeutics (SLNO) over the last 4 years, with Dec 2017 value amounting to $26,000.
- Soleno Therapeutics' Cost of Revenue fell 74.55% to $42,000 in Q2 2017 from the same period last year, while for Jun 2017 it was $690,306, marking a year-over-year decrease of 58.63%. This contributed to the annual value of $26,000 for FY2017, which is 98.28% down from last year.
- Latest data reveals that Soleno Therapeutics reported Cost of Revenue of $26,000 as of FY2017, which was down 98.28% from $1.5 million recorded in FY2016.
- Over the past 5 years, Soleno Therapeutics' Cost of Revenue peaked at $1.7 million during FY2015, and registered a low of $26,000 during FY2017.
- Over the past 3 years, Soleno Therapeutics' median Cost of Revenue value was $1.5 million (recorded in 2016), while the average stood at $1.1 million.
- Its Cost of Revenue has fluctuated over the past 5 years, first soared by 588.49% in 2015, then crashed by 98.28% in 2017.
- Yearly analysis of 4 years shows Soleno Therapeutics' Cost of Revenue stood at $252,359 in 2014, then soared by 588.49% to $1.7 million in 2015, then fell by 13.13% to $1.5 million in 2016, then slumped by 98.28% to $26,000 in 2017.